R. Hershberg
Journal of Clinical Oncology · 2001–2006
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Who trusts R. Hershberg
- G. Raposo (in Molecular Biology)
Papers from R. Hershberg's perspective
Ordered by how strongly the researchers R. Hershberg trusts endorse each paper. Same corpus, a different order for every researcher.
- Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. (New England Journal of Medicine)
- Individual Comparisons by Ranking Methods
- Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. (Journal of Clinical Oncology)
- Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 (Journal of Biological Chemistry)
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease (Nature)
- A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease (Nature)
- Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut (Applied and Environmental Microbiology)
- Cutting Edge: Bacterial Flagellin Activates Basolaterally Expressed TLR5 to Induce Epithelial Proinflammatory Gene Expression1 (Journal of Immunology)
- The microbiology of butyrate formation in the human colon. (FEMS Microbiology Letters)
- The immunological and genetic basis of inflammatory bowel disease (Nature reviews. Immunology)
Their papers
- Intestinal epithelial cells secrete exosome-like vesicles. (2001) — 711 citations
- Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. (2006) — 1,121 citations
- Bacterial flagellin is a dominant antigen in Crohn disease. (2004) — 598 citations